238 related articles for article (PubMed ID: 16497967)
21. Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma.
Yang S; Li JY; Xu W
Crit Rev Oncol Hematol; 2014 Aug; 91(2):113-22. PubMed ID: 24629840
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of BLyS action in B cell immunity.
Do RK; Chen-Kiang S
Cytokine Growth Factor Rev; 2002 Feb; 13(1):19-25. PubMed ID: 11750877
[TBL] [Abstract][Full Text] [Related]
23. A role for BLyS in the activation of innate immune cells.
Chang SK; Arendt BK; Darce JR; Wu X; Jelinek DF
Blood; 2006 Oct; 108(8):2687-94. PubMed ID: 16825497
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.
Do RK; Hatada E; Lee H; Tourigny MR; Hilbert D; Chen-Kiang S
J Exp Med; 2000 Oct; 192(7):953-64. PubMed ID: 11015437
[TBL] [Abstract][Full Text] [Related]
25. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.
Novak AJ; Darce JR; Arendt BK; Harder B; Henderson K; Kindsvogel W; Gross JA; Greipp PR; Jelinek DF
Blood; 2004 Jan; 103(2):689-94. PubMed ID: 14512299
[TBL] [Abstract][Full Text] [Related]
26. B-Lymphocyte stimulator: a new biomarker for multiple myeloma.
Jiang P; Yueguo W; Huiming H; Hongxiang Y; Mei W; Ju S
Eur J Haematol; 2009 Apr; 82(4):267-76. PubMed ID: 19187273
[TBL] [Abstract][Full Text] [Related]
27. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
[TBL] [Abstract][Full Text] [Related]
28. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.
Kern C; Cornuel JF; Billard C; Tang R; Rouillard D; Stenou V; Defrance T; Ajchenbaum-Cymbalista F; Simonin PY; Feldblum S; Kolb JP
Blood; 2004 Jan; 103(2):679-88. PubMed ID: 14504101
[TBL] [Abstract][Full Text] [Related]
29. The role of APRIL and BAFF in lymphocyte activation.
Schneider P
Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.
Yan M; Brady JR; Chan B; Lee WP; Hsu B; Harless S; Cancro M; Grewal IS; Dixit VM
Curr Biol; 2001 Oct; 11(19):1547-52. PubMed ID: 11591325
[TBL] [Abstract][Full Text] [Related]
31. A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas.
Pham LV; Tamayo AT; Yoshimura LC; Lo P; Terry N; Reid PS; Ford RJ
Immunity; 2002 Jan; 16(1):37-50. PubMed ID: 11825564
[TBL] [Abstract][Full Text] [Related]
32. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and release of B-lymphocyte stimulator from myeloid cells.
Nardelli B; Belvedere O; Roschke V; Moore PA; Olsen HS; Migone TS; Sosnovtseva S; Carrell JA; Feng P; Giri JG; Hilbert DM
Blood; 2001 Jan; 97(1):198-204. PubMed ID: 11133761
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB.
Huang G; Yang Y; Xu Z; Zhou P; Gong W; Li Y; Fan J; He F
Eur J Pharmacol; 2011 Jan; 650(1):451-7. PubMed ID: 20950605
[TBL] [Abstract][Full Text] [Related]
35. Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1.
Huang X; Di Liberto M; Cunningham AF; Kang L; Cheng S; Ely S; Liou HC; Maclennan IC; Chen-Kiang S
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17789-94. PubMed ID: 15591344
[TBL] [Abstract][Full Text] [Related]
36. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.
Shishodia S; Amin HM; Lai R; Aggarwal BB
Biochem Pharmacol; 2005 Sep; 70(5):700-13. PubMed ID: 16023083
[TBL] [Abstract][Full Text] [Related]
37. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching.
He B; Raab-Traub N; Casali P; Cerutti A
J Immunol; 2003 Nov; 171(10):5215-24. PubMed ID: 14607922
[TBL] [Abstract][Full Text] [Related]
38. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation.
Sasaki Y; Derudder E; Hobeika E; Pelanda R; Reth M; Rajewsky K; Schmidt-Supprian M
Immunity; 2006 Jun; 24(6):729-739. PubMed ID: 16782029
[TBL] [Abstract][Full Text] [Related]
39. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.
Nishio M; Endo T; Tsukada N; Ohata J; Kitada S; Reed JC; Zvaifler NJ; Kipps TJ
Blood; 2005 Aug; 106(3):1012-20. PubMed ID: 15860672
[TBL] [Abstract][Full Text] [Related]
40. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
